Hennion & Walsh Asset Management, Inc. Apellis Pharmaceuticals, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.1 Billion
- Q4 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 29,740 shares of APLS stock, worth $903,798. This represents 0.05% of its overall portfolio holdings.
Number of Shares
29,740
Previous 12,625
135.56%
Holding current value
$903,798
Previous $364,000
160.71%
% of portfolio
0.05%
Previous 0.02%
Shares
16 transactions
Others Institutions Holding APLS
# of Institutions
310Shares Held
113MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$473 Million0.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$361 Million14.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$338 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$298 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$176 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.34B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...